Tissue Retinol-Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment-Refractory Alopecia Areata: Association With Response to Baricitinib
January 2026
in “
Dermatologic Therapy
”
Studysummary This study found that elevated tissue RBP4 levels correlate with disease severity in alopecia areata and decrease after effective baricitinib treatment, while the rs3758539 polymorphism is linked to disease susceptibility but not to treatment response.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →